A sub-study of the Anticov trial:
Early treatment of vulnerable people with non-severe SARS-CoV-2 infection: a randomised multi-arm, multi-stage (MAMS) trial to assess the efficacy of several specific treatments in reducing the risk of clinical worsening or death in sub-Saharan Africa